Colorectal Cancer

Colorectal Cancer

1758-194X

1758-1958

Therapeutic Area

Diagnostic Imaging, Gastroenterology, Genomics, Nuclear Medicine, Oncology, Pharmacogenetics & Pharmacogenomics, Radiology, Surgery, Vaccines/Vaccinology

Biomedical Researchers, Colorectal Surgeons, Gastroenterologists, Oncologists, Outcomes Manager, Pharmaco-Epidemiologists, Physicians, Physicians - Medicine, Radiation Oncologists, Surgeons, Surgical Oncologists

Colorectal cancer is a major cause of morbidity and mortality, particularly in the developed world. Risk factors for colorectal cancer are on the rise in many countries; populations are aging, and obesity and diabetes are increasing. National screening programs are helping to detect cancer while it is still curable; however, colorectal cancer remains the third leading cause of cancer deaths in the USA and options are still limited for those with more advanced disease. Consequently, colorectal cancer is a major research priority for government, pharmaceutical companies and non-profit organizations. Research into diagnosis and optimum treatment of the disease is progressing rapidly, with new advances reported every day. Colorectal Cancer presents reviews, analysis and commentary. on all aspects of colorectal cancer. Colorectal Cancer provides a concise, readable overview of current and future management options in a fast-moving field, ideal for the busy clinician or healthcare professional. Each issue will provide high-quality Reviews of current and emerging topics, cutting-edge Editorials discussing contentious issues and independent Drug Evaluations assessing individual medicines and their role in current treatment practices. In addition, forward-looking Perspectives and Interviews will give leading experts the opportunity to present criticism or address controversy. The journal will also provide a disease-specific forum for Case Studies and Original Research Articles reporting new clinical findings. Coverage includes: Risk factors and prevention, Hereditary nonpolyposis colorectal cancer and other hereditary conditions causing colorectal cancer, Biomarkers for screening, Colonoscopy and sigmoidoscopy for screening and diagnosis, Surgery, Radiation therapy, Optimum chemotherapy regimes to maximize efficacy and minimize side effects, Monoclonal antibodies, Multimodality treatment, Prospects for new treatments, such as vaccines, Treatment of metastases, Follow-up care for colorectal cancer survivors.

No associations affiliated with this journal

Future Medicine Ltd.

Electronic Circulation Submission to Acceptance Acceptance to Online Publication Rejection Rate Frequency Journal Contact Author Submission Guidelines